Recruiting
Phase 2

Dendritic Cell Vaccine

Sponsor:

Jodi Maranchie

Code:

NCT05127824

Conditions

Carcinoma, Renal Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Autologous alpha-DC1/TBVA vaccine

Cabozantinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by Jodi Maranchie on 2025-05-04.